A recap of the top headlines from Contemporary OB/GYN in September 2026, spanning ACOG's respiratory vaccine guidance to the launch of the Missed & Dismissed podcast.
|Articles|July 3, 2012
DailyDx: Pelvic Pain with Amenorrhea
Author(s)Joe Antony, MD
This patient had a history of pelvic pain and five weeks amenorrhea with no h/o spotting. What is your diagnosis?
Advertisement
This patient had a history of pelvic pain and five weeks amenorrhea with no h/o spotting. What is your diagnosis?
Advertisement
Related to this article
A recap of Contemporary OB/GYN's top FDA and regulatory news from September 2026.
The Preeclampsia Foundation released 2 videos on postpartum recovery and long-term health after HDP.
AJOG research shows a cytokine storm could be detectable in maternal blood before the clinical onset of AFE.
CDC data show gestational hypertension rose 73% from 2016 to 2024, affecting 1 in 10 US mothers giving birth.
Missed the updated IDSA histoplasmosis guideline? This easy-to-read FAQ covers what clinicians caring for pregnant patients need to know.
Placentas from older mothers held less NAD+, and in aged pregnant mice, nicotinamide riboside or the CD38 inhibitor 78c restored placental NAD+ and improved fetal growth.
A real-world study presented at Psych Congress found that zuranolone's PPD symptom improvements were sustained through day 90.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
IMS: Fezolinetant's improvements in sleep quality, hot flashes as early as week 4
2
Wen Shen, MD, on recognizing perimenopause as a window for healthy aging
3
Top headlines in women's health from September 2026
4
FAQ: What does the rename from PCOS to PMOS mean for your patients?
5